Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 23312-56-3, Spectinomycin sulphate, Actinospectacin, Trobicin, Bz0h4tlf9x, Nsc100859
Molecular Formula
C14H26N2O11S
Molecular Weight
430.43  g/mol
InChI Key
XGBFWQUQYQIFLB-MTTMTQIXSA-N
FDA UNII
BZ0H4TLF9X

An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sulfuric acid;(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one
2.1.2 InChI
InChI=1S/C14H24N2O7.H2O4S/c1-5-4-6(17)14(20)13(21-5)22-12-10(19)7(15-2)9(18)8(16-3)11(12)23-14;1-5(2,3)4/h5,7-13,15-16,18-20H,4H2,1-3H3;(H2,1,2,3,4)/t5-,7-,8+,9+,10+,11-,12-,13+,14+;/m1./s1
2.1.3 InChI Key
XGBFWQUQYQIFLB-MTTMTQIXSA-N
2.1.4 Canonical SMILES
CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O.OS(=O)(=O)O
2.1.5 Isomeric SMILES
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.OS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
BZ0H4TLF9X
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Actinospectacin

2. Adspec

3. Ferkel Spectam

4. Kempi

5. Prospec

6. Salmosan T

7. Salmosan-t

8. Spectam

9. Spectam, Ferkel

10. Spectinomycin

11. Spectinomycin Dihydrochloride, Anhydrous

12. Spectinomycin Dihydrochloride, Pentahydrate

13. Spectinomycin Hydrochloride

14. Stanilo

15. Trobicin

2.3.2 Depositor-Supplied Synonyms

1. 23312-56-3

2. Spectinomycin Sulphate

3. Actinospectacin

4. Trobicin

5. Bz0h4tlf9x

6. Nsc100859

7. Xk 43-1

8. Sulfuric Acid;(1r,3s,5r,8r,10r,11s,12s,13r,14s)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one

9. U 18409

10. Unii-bz0h4tlf9x

11. Togamycin Sulfate (1:1)

12. Einecs 245-578-7

13. Mfcd00270185

14. Actinospectacin Sulfate

15. Schembl134977

16. Actinospectacin Sulphate

17. Chembl1969020

18. Dtxsid40945986

19. Yaa31256

20. Nsc-100859

21. Q-201733

22. Q27274974

23. (2r-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.))-decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4h-pyrano(2,3-b)(1,4)benzodioxin-4-one Sulfate

24. (2r-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.))-decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4h-pyrano(2,3-b)(1,4)benzodioxin-4-one Sulphate

25. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2r,4ar,5ar,6s,7s,8r,9s,9ar,10as)-, Sulfate (1:1)

26. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2r,4ar,5ar,6s,7s,8r,9s,9ar,10as)-, Sulphate (1:1)

27. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, Sulfate (1:1) (salt)

28. 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, Sulphate (1:1) (salt)

29. 4h-pyrano[2,4]benzodioxin-4-one, Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, [2r-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.)]-, Sulfate (1:1) (salt)

30. Sulfuric Acid--4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)decahydro-4h-pyrano[2,3-b][1,4]benzodioxin-4-one (1/1)

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 430.43 g/mol
Molecular Formula C14H26N2O11S
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count13
Rotatable Bond Count2
Exact Mass430.12573082 g/mol
Monoisotopic Mass430.12573082 g/mol
Topological Polar Surface Area213 Ų
Heavy Atom Count28
Formal Charge0
Complexity559
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)